These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
34. Pharmacophore modeling and density functional theory analysis for a series of nitroimidazole compounds with antitubercular activity. Tawari NR; Degani MS Chem Biol Drug Des; 2011 Sep; 78(3):408-17. PubMed ID: 21689377 [TBL] [Abstract][Full Text] [Related]
35. PA-824 exhibits time-dependent activity in a murine model of tuberculosis. Ahmad Z; Peloquin CA; Singh RP; Derendorf H; Tyagi S; Ginsberg A; Grosset JH; Nuermberger EL Antimicrob Agents Chemother; 2011 Jan; 55(1):239-45. PubMed ID: 20937781 [TBL] [Abstract][Full Text] [Related]
36. New tuberculosis drug enters human trials. Ahmad K Lancet Infect Dis; 2005 Aug; 5(8):475. PubMed ID: 16094736 [No Abstract] [Full Text] [Related]
38. Tuberculosis: new drug class investigated through public-private partnership. AIDS Treat News; 2000 Jul; (346):5-6. PubMed ID: 12170980 [No Abstract] [Full Text] [Related]
39. Novel drug combination for tuberculosis to be tested across 50 sites. Bagcchi S BMJ; 2014 May; 348():g3535. PubMed ID: 24868091 [No Abstract] [Full Text] [Related]
40. A concise and convergent synthesis of PA-824. Marsini MA; Reider PJ; Sorensen EJ J Org Chem; 2010 Nov; 75(21):7479-82. PubMed ID: 20929201 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]